A detailed history of Globeflex Capital L P transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Globeflex Capital L P holds 1,857 shares of PTCT stock, worth $139,832. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,857
Previous 1,857 -0.0%
Holding current value
$139,832
Previous $90,000 25.56%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$36.19 - $52.13 $67,204 - $96,805
1,857 New
1,857 $90,000
Q1 2019

May 10, 2019

SELL
$28.09 - $39.49 $89,888 - $126,368
-3,200 Closed
0 $0
Q3 2018

Nov 09, 2018

SELL
$33.9 - $47.77 $189,840 - $267,512
-5,600 Reduced 63.64%
3,200 $150,000
Q2 2018

Aug 10, 2018

BUY
$25.7 - $47.88 $226,160 - $421,344
8,800 New
8,800 $297,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $5.39B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Globeflex Capital L P Portfolio

Follow Globeflex Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.